3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
5
Plasma cell
3
Genitourinary
3
Other neoplasm
1
Other hematologic neoplasm
1
Other
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Classical hematology
1
CNS
1
Breast
1
Conditions
Head and Neck Neoplasms
1870
Squamous Cell Carcinoma of Head and Neck
1109
Nasopharyngeal Carcinoma
535
Thyroid Neoplasms
519
Mouth Neoplasms
347
Oropharyngeal Neoplasms
292
Laryngeal Neoplasms
197
Carcinoma, Squamous Cell
188
Neoplasms
187
Breast Neoplasms
183
Lung Neoplasms
182
Nasopharyngeal Neoplasms
160
Thyroid Nodule
154
Salivary Gland Neoplasms
135
Thyroid Cancer, Papillary
122
Neoplasm Metastasis
113
Carcinoma, Non-Small-Cell Lung
113
Hypopharyngeal Neoplasms
111
Melanoma
105
Prostatic Neoplasms
99
Esophageal Neoplasms
95
Colorectal Neoplasms
90
Thyroid Diseases
87
Uterine Cervical Neoplasms
82
Recurrence
81
Pancreatic Neoplasms
79
Ovarian Neoplasms
70
Sarcoma
68
Stomach Neoplasms
65
Xerostomia
62
Interventions
etelcalcetide hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Bone Diseases
×
Head & Neck
×
Clear all
NCT03960437
2023-09-21
Parsabiv-MBD
Columbia University
Phase 2
Completed
22 enrolled
14 charts